Pharmaceutical Technology
DECEMBER 15, 2022
Both pipeline products use Biotest’s newly developed production facility, which enables improved manufacturing of fibrinogen with higher purity, defined concentrations, viral safety, and good solubility.
The Pharma Data
MARCH 16, 2022
TIB Molbiol offers a broad range of VirSNiP variant test kits for the detection of key spike protein mutations. The company launched eight RUO VirSNiP test kits for use on LightCycler® and cobas z 480 analyzers, for the detection of key spike protein mutations present in the novel B.1.1.529 1.1.529 Omicron SARS-CoV-2 variant.
The Pharma Data
NOVEMBER 24, 2020
Management options to date were limited to hyperhydration, crystallization inhibitors and, in a minority of patients with a specific genotype, pyridoxine (vitamin B6). This is a revolutionary approach with the potential to transform the care of patients with genetic and other diseases.
Expert insights. Personalized for you.
130 
Let's personalize your content